Lymphedema Diagnosis and Treatment

Document Overview

Document Title

Lymphedema Diagnosis and Treatment

Authoring Societies

American Vein & Lymphatic Society

American Venous Forum

Society for Vascular Medicine

Document Publication Date

Mar 7, 2022

Page Last Reviewed/Updated

May 5, 2026

Document Type

Consensus Statement

Country of Publication

United States

Full Text Freely Available

Yes

Full Text Guideline

journals.sagepub.com/doi/full/10.1177/02683555211053532

Source Citation

 Lurie F, Malgor RD, Carman T, et al. The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatment. Phlebology. March 2022. doi:10.1177/02683555211053532
  
 

Supplemental Implementation Resources

• Quick-Reference Guide
• Quick-Reference Guide

Document Scope, Criteria, and Use Cases

Document Objectives

Lymphedema imposes a significant economic and social burden in modern societies. Controversies about its risk factors, diagnosis, and treatment permeate the literature. The goal of this study was to assess experts’ opinions on the available literature on lymphedema while following the Delphi methodology.

Scope

Assessment and Screening, Diagnosis, Management, Treatment

Diseases/Conditions (MeSH)

D008209 - Lymphedema

D008209 - Lymphedema

Keywords

Lymphedema

Inclusion Criteria

Male, Female, Adult, Older Adult

Health Care Settings

Ambulatory, Hospital, Operating and Recovery Room, Outpatient

Intended Users

Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents

75

Includes peer/external review process?

Yes

Includes public comment process?

No

Methodologist involvement?

Yes

Patient involvement?

No

Includes multi-disciplinary group?

Yes

Includes systematic review?

Yes

Grades quality of strength of evidence?

No

Grades quality of strength of recommendation?

No

Discloses funding source?

Yes

Discloses conflicts of interest?

Yes

Includes benefits/harms analysis with recommendations?

No